Zobrazeno 21 - 30
of 50
pro vyhledávání: '"Lucia Villalon"'
Autor:
Roberto Hernández-Martin, Soledad Noya, Javier de la Serna, Pilar Giraldo, Ana Roy, Javier García-Frade, Elisa Luño, Vicente Diaz-Morant, Koldo Atutxa, Lucia Villalon, Blanca Medrano Engay
Publikováno v:
Molecular Genetics and Metabolism. 123:S93-S94
Autor:
Jesus J. Fraile, Izaskun Arenaz, Marcio Andrade-Campos, Laura López de Frutos, Maria Teresa Molero, Jorge J. Cebolla, Horacio Cano, Jose Luis Capablo, Mercedes Roca, Pilar Irún, Jesús Villarrubia, Pilar Giraldo, Abelardo Bárez, Lucia Villalon
Publikováno v:
Molecular Genetics and Metabolism. 126:S22
Autor:
Soledad Noya, Jesús María Hernández-Rivas, Maria Luisa Lozano, Javier García-Frade, Lucia Villalon, Daiana Ibarretxe, Maria Lourdes Hermosin, Santiago Nieto, Laura López de Frutos, Marcio Andrade-Campos, Abelardo Bárez, Maria Angeles Perez-Saenz, Teresa Molero, Jorge J. Cebolla, Ana I Arribas, Jesús Villarrubia, Pilar Giraldo, Pilar Irún
Publikováno v:
Blood. 132:4942-4942
Type 1 Gaucher disease (GD1) is caused by the deficiency in the lysosomal enzyme glucocerebrosidase and causes the accumulation of glucocerebroside mainly in macrophages, inducing deterioration of the organs in which it is deposited.The new substrate
Autor:
Jorge J. Cebolla, Jesús Villarrubia, Jesus J. Fraile, Marcio Andrade-Campos, Pilar Irún, Abelardo Bárez, Horacio Cano, Laura López de Frutos, Mercedes Roca-Espiau, Izaskun Arenaz, Pilar Giraldo, Jose Luis Capablo, Teresa Molero, Lucia Villalon
Publikováno v:
Blood. 132:1110-1110
Gaucher disease (GD), has a pan-ethnic distribution with incidence in non-Ashkenazi Jewish population about 1/70-140 thousand inhabitants. The deficiency in lysosomal acid beta-glucosidase enzyme secondary to variants in the GBA gene with autosomal r
Autor:
Ricardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, Alejandro Martín-Muñoz, Juan Manuel Rosa-Rosa, Jordi Ribera, Olga García, Ana Jimenez-Ubieto, Gonzalo Carreño-Tarragona, María Linares, Laura Rufián, Alexandra Juárez, Jaime Carrillo, María José Espino, Mercedes Cáceres, Sara Expósito, Beatriz Cuevas, Raúl Vanegas, Luis Felipe Casado, Anna Torrent, Lurdes Zamora, Santiago Mercadal, Rosa Coll, Marta Cervera, Mireia Morgades, José Ángel Hernández-Rivas, Pilar Bravo, Cristina Serí, Eduardo Anguita, Eva Barragán, Claudia Sargas, Francisca Ferrer-Marín, Jorge Sánchez-Calero, Julián Sevilla, Elena Ruíz, Lucía Villalón, María del Mar Herráez, Rosalía Riaza, Elena Magro, Juan Luis Steegman, Chongwu Wang, Paula de Toledo, Valentín García-Gutiérrez, Rosa Ayala, Josep-Maria Ribera, Santiago Barrio, Joaquín Martínez-López
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The screening of the BCR::ABL1 kinase domain (KD) mutation has become a routine analysis in case of warning/failure for chronic myeloid leukemia (CML) and B-cell precursor acute lymphoblastic leukemia (ALL) Philadelphia (Ph)-positive patient
Externí odkaz:
https://doaj.org/article/900f483793a442ea9469078a704f59fa
Autor:
Antonio Julia, Jorge L. Montserrat, Pilar Irún, Jaime Dalmau, Pilar Giraldo, Javier de la Serna, Jesús M. Hernández-Rivas, Elisa Luño, Antonio Figueredo, Pilar Alfonso, M.A. Fernandez-Galan, Antonio Vidaller, Miguel Pocovi, Francisca Marín-Jimenez, Guillermo Martín-Nuñez, Lucia Villalon
Publikováno v:
Blood Cells, Molecules, and Diseases. 46:115-118
Recently, an acute restriction of imiglucerase has occurred as a result of viral contamination and manufacturing problems. A position statement from the European Working Group for Gaucher Disease and European Gaucher Alliance established a set of key
Autor:
Emilio Montserrat, José-Angel Martínez-Climent, Mireia Camós, Jesús Odriozola, Francisco Cervantes, Javier García-Conde, Lucia Villalon, Juan Carlos Hernández-Boluda, Raquel Del Campo
Publikováno v:
British Journal of Haematology. 120:500-504
Imatinib mesylate (STI571) is a highly effective and well-tolerated treatment for patients with chronic-phase chronic myeloid leukaemia (CML), but information on its efficacy and tolerance in intensively pretreated patients is scarce. Thirty-three ch
Autor:
Elisa Luño, Lucia Villalon, Ana Roy, Pilar Giraldo, Javier Garcia-Frade, Vicente Diaz-Morant, Javier de la Serna, Blanca Medrano Engay, Koldo Atutxa, Roberto Hernández-Martin, Soledad Noya
Publikováno v:
Molecular Genetics and Metabolism. 120:S94
Publikováno v:
Advances in Hematology, Vol 2014 (2014)
Advances in Hematology
Advances in Hematology
Febrile neutropenia is one of the most serious complications in patients with haematological malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic therapy can prolong survival. This paper reviews the guidelines
Autor:
Alberto Cantalapiedra, J. G. Larana, Jesús M. Cesar, José Luis Navarro, Angel Garcı́a Avello, Jaime Perez de Oteyza, Lucia Villalon, Javier López, Jesús Odriozola
Publikováno v:
Thrombosis Research. 99:439-446
The objective of the present study was to analyze whether veno-occlusive disease (VOD) is based on specific findings or whether this syndrome is the exacerbation of changes in hemostatic parameters that develop following hematopoietic stem cell trans